Anemia
Conference Coverage
Emerging sickle cell agents target new pathways
CONCORD, N.C. – There are a number of new drugs in the sickle cell disease pipeline, and researchers are investigating gene therapy using patients...
Conference Coverage
Dedicated sickle cell center offers roadmap for care
CONCORD, N.C. – The Georgia Comprehensive Sickle Cell Center includes a dedicated emergency room.
News
Rigosertib produces better OS in MDS than tAML
Rigosertib has demonstrated activity and tolerability in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia transformed from...
News
Drug can treat severely ill SCD patients, case suggests
ATLANTA—Results of a case study suggest voxelotor (previously GBT440) can be effective in severely ill patients with sickle cell disease (SCD)....
News
Generic azacitidine approved in Canada
Health Canada has approved Dr.
Latest News
CRISPR on the Senate health committee menu
News
Results support using MTD of HU in kids with SCA
Dosing of hydroxyurea (HU) in young patients with sickle cell anemia (SCA) should target a fetal hemoglobin (HbF) level above 20%, according to...
News
CHMP recommends approval of romiplostim in kids
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the approved indication for...
News
Drug receives orphan designation for treatment of PNH
The US Food and Drug Administration (FDA) has granted orphan drug designation to ACH-4471 for the treatment of paroxysmal nocturnal hemoglobinuria...
News
Ferric citrate approved to treat iron-deficiency anemia
The US Food and Drug Administration (FDA) has approved ferric citrate (Auryxia) to treat iron-deficiency anemia in adults with chronic kidney...
News
FDA approves wider use of hematology analyzer
The US Food and Drug Administration (FDA) has expanded the approved use of the XW-100 Automated Hematology Analyzer. The analyzer can now be used...